The forecast for influenza mortality among females in the US from 2024 to 2028 shows a constant value of 700 deaths per hundred women, expressed in standardized rates. This steady figure suggests no expected variation in mortality rates over these years compared to 2023. With no change in forecasted rates, this equates to a year-on-year variation of 0%. The compounded annual growth rate (CAGR) also stands at 0%, reflecting a stable trend with no increase or decrease forecast for this period.
Future trends to watch for include potential impacts of advancements in influenza vaccinations, improvements in healthcare accessibility, and public health campaigns. Environmental and social factors, such as changes in virus strains or population health behaviors, could also influence these steady projections. Monitoring these elements will be crucial for reassessing the forecast as new data become available.
